Abstract:413 Objectives: Melanin, a naturally occurring biopolymer, has many fascinating characteristics such as good biocompatibility and biodegradability, strong chelating capability to metal ions, and excellent antioxidant activities. Thus, melanin is attracting intense attention for molecular imaging and treating of reactive oxygen species (ROS)-related diseases. Acute kidney injury (AKI), a common ROS-related renal disease, is in urgent need of effective treatment. Nanomedicine shows great potential in targeted drug delivery, but it still faces the huge challenge of controlling the accumulation of nanoparticles in kidney. Our goal is to develop a melanin ultra-small nanostructure for good renal accumulation and AKI therapy in mice. Methods: Manganese (Mn) ions chelated melanin ultra-small nanoparticles (MMP) were prepared via a one-pot micelle formation technique and further treated with PEGylation (MMPP). Because of the intrinsic chelating function of melanin, radionuclide Zr-89 (half-life: 78.4 h) labeled MMPP (89Zr-MMPP) was obtained by chelator-free labeling. Positron emission tomography (PET) imaging of 89Zr-MMPP and magnetic resonance (MR) imaging of MMPP were performed to evaluate the biodistribution in AKI mice. The AKI model was induced by intramuscular injection of 50% glycerol into both hind limbs of mice (8 mL/kg). MMPP was intravenously injected for AKI therapy with different doses. The therapeutic effect of MMPP was determined by measuring serum creatinine and blood urea nitrogen concentrations as well as kidney tissue staining. Results: The MMP and MMPP are ultra-small nanodots with sizes of 3.4 nm and 4.5 nm, respectively. The r1 value of MMPP was calculated to be 46.5 mM−1 s−1 at 4.7 T, which is a comparatively high value among reported relaxivities of nanosized Mn-based MR contrast agents and is about 7.5 times larger than that of gadobenate dimeglumine (Gd-BOPTA, a gadolinium-based contrast agent). The MR imaging revealed the enhanced T1-weighted MR signal within the kidneys of AKI mice after intravenous injection of MMPP. PET imaging also showed good accumulation of MMPP in the kidneys of AKI mice (13.8 ± 1.7 %ID/g at 10 min post-injection and 4.8 ± 0.4 %ID/g at 24 h post-injection; n=3). In addition, MMPP showed almost no toxicity to the major organs of healthy mice even at a high dose (1 mg of melanin per mouse). Furthermore, MMPP was found to alleviate AKI at the dose of 200 µg melanin per mouse and therapeutically effective at the dose of 500 µg melanin per mouse, which was confirmed by serum tests and kidney tissue staining. Conclusion: Based on the PET and MR bimodal imaging, MMPP showed a good renal accumulation in AKI mice, which enable MMPP to treat AKI induced by 50% glycerol in vivo. Moreover, MMPP may serve as a renal protective material to prevent or treat other ROS-related kidney diseases.

Integration of Melanin-Resveratrol Nanosystem for the Diagnostic-therapeutic of Renal Fibrosis

Enhanced Ferritin‐Manganese Interaction by Nanoplatinum Growth Enabling Liver Fibrosis 3D Magnetic Resonance Visualization and Synergistic Therapy with Real‐Time Monitoring

Amide Proton Transfer-Weighted Magnetic Resonance Imaging for Application in Renal Fibrosis: A Radiological-Pathological-Based Analysis

A Melanin‐Based Natural Antioxidant Defense Nanosystem for Theranostic Application in Acute Kidney Injury

Naturally Biocompatible Melanin Based Iron-Complex Nanoparticles for Ph-Responsive Magnetic Resonance Imaging.

Integrin-Targeted Theranostic Nanoparticles for Clinical MRI-Traceable Treatment of Liver Fibrosis

Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease

Melanin/melanin-like nanoparticles: As a naturally active platform for imaging-guided disease therapy

Assessment of renal fibrosis in murine diabetic nephropathy using quantitative magnetization transfer MRI

Detection of Kidney Dysfunction through In Vivo Magnetic Resonance Imaging with Renal-Clearable Gadolinium Nanoprobes

Highly Sensitive Early Diagnosis of Kidney Damage Using Renal Clearable Zwitterion‐Coated Ferrite Nanoprobe via Magnetic Resonance Imaging In Vivo

Engineering Melanin Nanoparticles as an Efficient Drug–Delivery System for Imaging‐Guided Chemotherapy

Fluorinated 1,7-DO2A-Based Iron(II) Complexes as Sensitive 19F MRI Molecular Probes for Visualizing Renal Dysfunction in Living Mice

Mesoscale nanoparticles encapsulated with emodin for targeting antifibrosis in animal models

Manganese Ions Chelated Melanin Ultra-Small Nanostructure for PET/MR Bimodal Imaging-Guided Acute Kidney Injury Therapy

In Vivo Nano Contrast-Enhanced Photoacoustic Imaging for Dynamically Lightening the Molecular Changes of Rheumatoid Arthritis

Platelet membrane biomimetic nanoparticle-targeted delivery of TGF-β1 siRNA attenuates renal inflammation and fibrosis

Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma

Simultaneous multimodal imaging and photothermal therapy via renal-clearable manganese-doped copper sulfide nanodots

Transferring Biomarker into Molecular Probe: Melanin Nanoparticle as a Naturally Active Platform for Multimodality Imaging

Nanoparticle-Based MRI-Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF-β Signaling